Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06728319 · ClinicalTrials.gov registry record
A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World
A clinical trial of Lung Nodules, sponsored by Biodesix.
- Active
- Registry status
- 4,000
- Enrollment target
- 5
- Study locations
NCT06728319: Active study of Lung Nodules, sponsored by Biodesix.
NCT06728319 is a study of Lung Nodules that is active but no longer recruiting, run by Biodesix. The registered enrollment target is 4,000 participants. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06728319, a study of Lung Nodules, is active but no longer recruiting, sponsored by Biodesix.
- ACTIVE NOT RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is a multicenter retrospective chart review. Sites with at least 100 patients tested with the IC and AAT tests, who have index dates (date of IC and AAT testing) at least one year prior to data collection date will be eligible for participation.
Primary Outcome
To assess the performance of the AAT test in a real-world patient population: 1. Sensitivity of the AAT test at 24 months 2. Specificity of the AAT test at 24 months 3. Positivity predictive value of the AAT test at 24 months
Conditions Studied
Study Locations (5)
Florida
- Pulmonary & Sleep of Tampa Bay - Brandon
- White-Wilson Medical Center - Fort Walton Beach
Kentucky
- The Lung and Sleep Disorder Institute - Somerset
Massachusetts
- Southcoast Health System - Fairhaven
Pennsylvania
- The Lung Center, PC - DuBois
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2024-09-19 |
| Est. Completion | 2027-07-31 |
What the registry record for NCT06728319 still lists
NCT06728319 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Lung Nodules appearing as the primary indexed condition, and to 0 interventions.
NCT06728319 lists 5 locations in 4 states (Florida, Kentucky, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06728319 about?
NCT06728319 is a clinical study titled "A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World". This study is a multicenter retrospective chart review. Sites with at least 100 patients tested with the IC and AAT tests, who have index dates (date of IC and AAT testing) at least one year prior to data collection date will be eligible for participation.
What is the current status of trial NCT06728319?
This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2024-09-19. Estimated completion is 2027-07-31.
What conditions does trial NCT06728319 study?
This clinical trial studies the following conditions: Lung Nodules.
Who is sponsoring clinical trial NCT06728319?
This trial is sponsored by Biodesix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06728319 being conducted?
This trial has 5 study locations across Florida, Kentucky, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Nodules
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI